Company
Sydney, NSW
Every investor coverage indicates participated in a round Smart Sparrow raised.
Investors whose own portfolio pages list Smart Sparrow, even though we haven't found any coverage of the round yet.
| Investor | Listed on |
|---|---|
| MA Financial Group | its portfolio page ↗ |
| MA Growth Ventures | its portfolio page ↗ |
Companies Smart Sparrow acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dror Ben-Naim | CEO | OneVentures portfolio |
Stories naming Smart Sparrow. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Pearson has bought Smart Sparrow's adaptive learning technology in a deal valuing the Sydney edtech firm's assets at US$25 million, to strengthen Pearson's digital learning platform and e-book offerings.
Venture fund Uniseed led a million-dollar slice of probiotic drinks maker PERKii's four-million-dollar round, its first deal from its new $50 million fund, to fund a national launch.
GBS Ventures reports Novartis has agreed to acquire chronic-pain drug developer Spinifex Pharmaceuticals for US$200 million upfront plus milestones, recalling the company's 2005, 2008 and 2014 venture rounds and its Australian investors.
Also GBS Ventures·Brandon Capital portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·novartis.com·clinicalleader.com·Brandon Capital portfolio·Startup Daily·Startup Daily·Startup Daily·anthillonline.com·@AuManufacturing·materresearch.org.au·Business News Australia